Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 bln ReutersBristol Myers to Acquire Karuna, a Neuroscience Drugmaker, for $14 Billion The New York TimesKaruna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal CNBCKRTX Stock Soars And Breaks Out On Bristol Myers’ $14 Billion Takeover Investor’s Business DailyRocket Lab, Coinbase, Bristol Myers-Karuna deal: Trending tickers Yahoo Finance
